4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and outcomes of breast cancer patients with leptomeningeal metastasis at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Morikawa, A.; Jordan, L.; Rozner, R.; Patil, S.; Boire, A. A.; Pentsova, E.; Seidman, A. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I, first-in-human dose study of the dual PI3K/mTOR inhibitor LY3023414 (LY) in patients (pts) with advanced cancer
    Meeting Abstract

    Moore, K. N.; Varghese, A. M.; Hyman, D. M.; Callies, S.; Lin, J.; Wacheck, V.; Pant, S.; Bauer, T. M.; Bendell, J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician's choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
    Meeting Abstract

    Monk, B. J.; Grisham, R. N.; Marth, C.; Banerjee, S. N.; Hilpert, F.; Coleman, R. L.; Pujade-Lauraine, E.; Pignata, S.; Mirza, M. R.; Oza, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety of infusing ipilimumab (ipi) over 30 minutes (min)
    Meeting Abstract

    Momtaz, P.; Park, V.; Panageas, K.; Guillen, J. D.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Genetically engineered NY-ESO-1 specific T cells in HLA-A201+ patients with advanced cancers
    Meeting Abstract

    Merchant, M. S.; Cristea, M. C.; Stadtmauer, E. A.; Tap, W. D.; D'Angelo, S. P.; Grupp, S. A.; Holdich, T.; Binder-Scholl, G.; Jakobsen, B. K.; Odunsi, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma
    Meeting Abstract

    Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis
    Meeting Abstract

    McNeish, I. A.; Oza, A. M.; Coleman, R. L.; Scott, C. L.; Konecny, G. E.; Tinker, A.; O'Malley, D. M.; Brenton, J.; Kristeleit, R. S.; Bell-Mcguinn, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Histopathological markers at craniotomy and outcome in breast cancer brain metastases
    Meeting Abstract

    McKee, M. J.; Trembath, D. G.; Deal, A. M.; Keith, K.; Midkiff, B. R.; Nikolaishvilli-Feinberg, N.; Garrett, A.; Blackwell, K. L.; Leone, J. P.; Hamilton, R. L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of buparlisib (BKM120) with bevacizumab (BEV) in patients (pts) with metastatic renal cell carcinoma (mRCC) progressing on prior vascular endothelial growth factor (VEGF) therapies
    Meeting Abstract

    McKay, R. R.; Werner, L.; Harshman, L. C.; Bellmunt, J.; Sweeney, C.; Rosenberg, J. E.; VanAllen, E.; Walsh, M. K.; Vaishampayan, U. N.; McDermott, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of an inpatient hematology-oncology ward rotation on medical house staff interest in pursuing hematology-oncology as a career
    Meeting Abstract

    Mcfarland, D. C.; Holland, J.; Holcombe, R. F.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save